JN AJP: Advances in Physiology Education
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Neurophysiol 98: 467-477, 2007. First published May 16, 2007; doi:10.1152/jn.00117.2007
0022-3077/07 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
98/1/467    most recent
00117.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhao, J.
Right arrow Articles by Chahine, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhao, J.
Right arrow Articles by Chahine, M.

Lidocaine Promotes the Trafficking and Functional Expression of Nav1.8 Sodium Channels in Mammalian Cells

Juan Zhao1, Rahima Ziane1, Aurélien Chatelier1, Michael E. O'Leary2 and Mohamed Chahine1

1Le Centre de Recherche Université Laval Robert-Giffard and Department of Medicine, Laval University, Quebec, Quebec, Canada; and 2Jefferson Medical College, Jefferson University, Philadelphia, Pennsylvania

Submitted 2 February 2007; accepted in final form 9 May 2007


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Nociceptive neurons of the dorsal root ganglion (DRG) express a combination of rapidly gating TTX-sensitive and slowly gating TTX-resistant Na currents, and the channels that produce these currents have been cloned. The Nav1.7 and Nav1.8 channels encode for the rapidly inactivating TTX-sensitive and slowly inactivating TTX-resistant Na currents, respectively. Although the Nav1.7 channel expresses well in cultured mammalian cell lines, attempts to express the Nav1.8 channel using similar approaches has been met with limited success. The inability to heterologously express Nav1.8 has hampered detailed characterization of the biophysical properties and pharmacology of these channels. In this study, we investigated the determinants of Nav1.8 expression in tsA201 cells, a transformed variant of HEK293 cells, using a combination of biochemistry, immunochemistry, and electrophysiology. Our data indicate that the unusually low expression levels of Nav1.8 in tsA201 cells results from a trafficking defect that traps the channel protein in the endoplasmic reticulum. Incubating the cultured cells with the local anesthetic lidocaine dramatically enhanced the cell surface expression of functional Nav1.8 channels. The biophysical properties of the heterologously expressed Nav1.8 channel are similar but not identical to those of the TTX-resistant Na current of native DRG neurons, recorded under similar conditions. Our data indicate that the lidocaine acts as a molecular chaperone that promotes efficient trafficking and increased cell surface expression of Nav1.8 channels.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Voltage-gated Na channels are membrane proteins that play an important role in the rapid electrical signaling in nerve fibers (Hille 2001Go). The nociceptive neurons of the dorsal root ganglia (DRG) express a unique combination of tetrodotoxin (TTX)-sensitive and -resistant Na channels that play a key role in the physiology and pathophysiology of pain (Waxman et al. 2000Go). Several Na channels have been cloned from peripheral nerve; Nav1.7 (PN1 for peripheral nerve Na channel 1) encodes for a rapidly gating TTX-sensitive Na channel that is broadly expressed in both large and small DRG neurons (Sangameswaran et al. 1997Go). Nav1.8 (PN3) encodes for a slowly gating TTX-resistant Na channel that is highly localized within the small nociceptive neurons of the DRG neurons (Sangameswaran et al. 1996Go). Differences in the biophysical properties and the pharmacology of these Na channels contribute to the unique electrical properties of sensory nerve fibers.

Several distinct components of TTX-R Na current have been observed in DRG sensory neurons (Elliott and Elliott 1993Go; Kostyuk et al. 1981Go; Ogata and Tatebayashi 1993Go; Roy and Narahashi 1992Go; Rush et al. 1998Go; Scholz et al. 1998Go). One component displays a low threshold for activation and rapid kinetics and is believed to be produced by the Nav1.5 channel, which is highly expressed in embryonic sensory neurons and at a lower level in adult neurons (Renganathan et al. 2002Go). A second component of TTX-R current activates at relatively depolarized voltages, has comparatively slow gating kinetics, and rapidly recovers at hyperpolarized voltages (Elliott and Elliott 1993Go; Kostyuk et al. 1981Go; Ogata and Tatebayashi 1993Go; Roy and Narahashi 1992Go; Rush et al. 1998Go). These properties are similar to what has been described for the Nav1.8 channel (Akopian et al. 1999Go). A third component of TTX-R current has a relatively hyperpolarized threshold for activation (approximately equal to –80 mV) and displays little inactivation (Cummins et al. 1999Go). The Nav1.9 channel appears to underlie this component of DRG Na current (Cummins et al. 1999Go; Fjell et al. 2000Go).

The presence of multiple overlapping components of TTX-R Na current in small DRG neurons has complicated the detailed biophysical characterization of the underlying Na channels. The cloning of the Nav1.8 channel raised the prospect of its in vitro expression that would permit detailed electrophysiological characterization of the isolated channels (Akopian et al. 1996Go; Sangameswaran et al. 1996Go). The Nav1.8 channel has been expressed in Xenopus oocytes, and the properties of the heterologously expressed channels are in good agreement with those of the native TTX-R Na current of DRG neurons (Akopian et al. 1996Go; Sangameswaran et al. 1996Go; Vijayaragavan et al. 2001Go). By contrast, attempts to heterologously express the Nav1.8 channel in cultured mammalian cells have been met with limited success (John et al. 2004Go; Vijayaragavan et al. 2004Go). Although the reasons for the poor expression of the Nav1.8 channels in cultured cells are not known, it is generally believed to result from a trafficking defect that reduces the cell surface expression of functional channels (Okuse et al. 2002Go).

A number of factors appear to regulate the expression of Nav1.8 channel in mammalian cell lines. Interaction of Nav1.8 with accessory proteins appears to either promote the translocation to the plasma membrane or stabilize channels within the plasma membrane. Annexin II light chain (p11) enhances Nav1.8 expression by directly interacting with the cytoplasmic N terminus of the channel protein resulting in translocation to the plasma membrane (Okuse et al. 2002Go). Co-expression of the accessory beta3 subunit, annexin II light chain (p11), and clatherin-associated protein-1A (CAP-1A) appear to be important regulators of Nav1.8 expression (John et al. 2004Go; Liu et al. 2005Go; Okuse et al. 2002Go). Whereas beta3 and p11 were reported to enhance cell surface expression, CAP-1A reduces the density of the expressed Nav1.8.

Despite the enhanced trafficking produced by accessory proteins (beta3 and p11), the current density of the heterologously expressed Nav1.8 channel remains relatively low by comparison to the native TTX-R current of DRG neurons and the Nav1.7 channel expressed under similar conditions (Vijayaragavan et al. 2004Go). As-yet-unidentified factors or regulatory mechanisms appear to contribute to the efficient trafficking and cell surface expression of the Nav1.8 channel. Increases in nociceptor excitability and changes in the level and distribution of Nav1.8 expression were associated with acute nerve injury and inflammatory reactions (McCleskey and Gold 1999Go). Understanding the mechanisms governing Nav1.8 trafficking therefore has important implications for the peripheral sensitization to painful stimuli linked to tissue damage and nerve injury.

Recently it has been shown that in several channelopathies, mutations in channel proteins that induce misfolding and therefore the retention of the channel in the ER can be rescued by chemical chaperones or pharmacological ligands (Morello et al. 2000Go). This is the case for mutations that cause the Brugada syndrome an inherent cardiac disorder and that the defect of the misfolding was rescued by the antiarrhythmic drug mexiletine (Valdivia et al. 2002Go).

Chemical chaperones are small molecules that assist folding and restore the trafficking of receptors and channels (Morello et al. 2000Go). In this study, we investigated the effects of the local anesthetic lidocaine on the expression of the Nav1.8 channel in tsA201 cells, a transformed variant of the HEK293 cell line. Our data indicate that lidocaine acts as a chemical chaperon that promotes Nav1.8 trafficking to the plasma membrane. The biophysical properties of the heterologously expressed Nav1.8 channels are similar to but not identical to those of the TTX-resistant Na current recorded under identical conditions from DRG neurons.


    METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Heterologous expression of Nav1.8 in tsA201 cells

The tsA201 cell line is a mammalian cell line derived from human embryonic kidney HEK 293 cells by stable transfection with SV40 large T antigen (Margolskee et al. 1993Go). Cells were grown in high glucose DMEM supplemented with FBS (10%), L-glutamine (2 mM), penicillin (100 U/ml) and streptomycin (10 mg/ml) (Gibco BRL Life Technologies, Burlington, Ontario, Canada). Cells were incubated in a 5% CO2 humidified atmosphere. Transfections of tsA201 cells were carried out using the calcium phosphate method as previously described (Margolskee et al. 1993Go).

The beta1 subunit was co-expressed with Nav1.8. The human Na+ channel beta1-subunit and CD8 were constructed in the piRES vector (piERS/CD8/beta1) (Invitrogene Corporation, Carlsbad, CA). Transfected cells were briefly (<5 min) preincubated with CD8 antibody-coated beads prior to recording (Dynabeads M-450 CD8-a). Cells expressing the piRES/CD8/beta1 bicistronic vector were decorated with CD8 beads, which were used to identify cells for patch-clamp analysis (Margolskee et al. 1993Go). Transfected tsA201 cells were then pretreated for 24 h with 1 mM lidocaine. The cells were subsequently incubated for 3–4 h in lidocaine-free media immediately prior to electrophysiological recordings.

Isolation of dorsal root ganglion neurons

Seven-day-old rat pups are anesthetized with isoflurane before decapitation and the dorsal root ganglia from all accessible levels of the spinal cord harvested. Excess connective tissues were removed and the ganglion placed in 3 ml of Hank's balanced salt solution (HBSS, Gibco) supplemented with 10 mM HEPES. The ganglions were incubated for 30 min at 37°C in 2 ml of HBSS/HEPES containing 1.5 mg/ml collagenase (Sigma-Aldrich, St. Louis, MO). The ganglia were washed with HBSS/HEPES before adding 1 mg/ml trypsin (Sigma-Aldrich) and incubating an additional 30 min at 37°C. Trypsin was removed and the ganglia were transferred to L-15 Leibovitz media (Gibco) supplemented with 1% fetal bovine serum (FBS, Gibco), 2 mM glutamine, 24 mM NaHCO3, 38 mM glucose, 2% penicillin-streptomycin (Gibco), and 50 ng/ml nerve growth factor (Sigma-Aldrich). The ganglia were dissociated by gentle titration using fire-polished Pasteur pipettes, and the dissociated neurons were plated onto 35 mm dishes containing 2 ml of the supplemented Leibovitz media. Dissociated neurons (≤20 µm, 8–12 pF of capacitance) were suitable for patch-clamp studies 1–2 h after plating. Neonatal rats were killed in accordance with the animal welfare protocols of our institution.

Electrophysiology

Macroscopic Na currents from tsA201 transfected cells were recorded using the whole cell configuration of the patch-clamp technique (Chahine et al. 2004Go). Command pulses were generated and current recorded using pCLAMP software v8.0 and an Axopatch 200 amplifier (Molecular Devices, Union City, CA). Patch electrodes were fashioned from borosilicate glass (Corning 8161) and coated with silicone elastomer (Sylgard, Dow-Corning, Midland, MI) to minimize stray capacitance. Current recordings were made using low-resistance electrodes (<1M{Omega}), and the series resistance was compensated at values ≥80%, to minimize voltage-clamp errors. Whole cell currents were filtered at 5 kHz, digitized at 10 kHz, and stored on a microcomputer equipped with an AD converter (Digidata 1300, Molecular Devices). Data analysis was performed using a combination of pCLAMP software v9.0 (Molecular Devices), Microsoft Excel and SigmaPlot for Windows version 8.0 (SPS, Chicago, IL). The current signal was low-pass filtered at 2 kHz and digitalized at a sampling rate of 100 µs during acquisition. Traces shown were low-pass filtered at 1.5 kHz using a digital filter of Clampfit software.

Solutions and reagents

For whole cell recordings, the patch pipette contained (in mM) 5 NaCl, 135 CsF, 10 EGTA, and 10 Cs-HEPES. The pH was adjusted to 7.4 using 1 N CsOH. The bath solution contained (in mM) 150 NaCl, 2 KCl, 1.5 CaCl2, 1 MgCl2 10 glucose, and 10 Na-HEPES. The pH was adjusted to 7.4 with 1 N NaOH. For Na current recording from DRG neurons, the extracellular solution contained instead 140 mM NaCl and the intracellular solution contained 35 mM NaCl. A correction for the liquid junction potential between the patch pipette and the bath solutions (–7 mV) was applied to the command pulses. The recordings were made 10 min after obtaining the whole cell configuration to allow the current to stabilize and to fully dialyze the cell with pipette solution. The Nav1.8 {alpha}-subunit and the beta1 auxiliary subunit were cloned in our laboratory as described previously (Vijayaragavan et al. 2001Go).

For single-channel recording, 3–5 M{Omega} patch electrodes were used. Patch electrodes were coated with Sylgard to reduce their capacitance and lower noise emission. The bath solution contained a high concentration of potassium composed of (in mM) 100 K-aspartate, 50 KCl, 1.5 CaCl2, 1 MgCl2, 10 glucose, and 10 K-HEPES (pH = 7.4). This solution was used to depolarize the cell, thereby making the applied command potential approximately equal to the voltage across the membrane patch. The patch pipette solution contained (in mM) 150 NaCl, 10 TEA-Cl, (to block endogenous potassium channels), 2 KCl, 1.5 CaCl2, 1 MgCl2, 10 glucose, and 10 Na-HEPES (pH = 7.4). Single-channel currents were recorded using an Axopatch 200B amplifier, a Digidata 1200 acquisition system, and pCLAMP v9 (Molecular Devices). Single-channel currents were filtered at 2 kHz and sampled at 100 kHz. Single-channel currents were recorded at room temperature (22–23°C).

Immunocytochemistry

Transfected tsA201 cells were permeabilized using 0.1% Triton in 1 mM PBS-0.5% BSA solution before incubation with antibodies. Cells were fixed using a 1:3 acetone/methanol solution for 20 min. The mouse anti-Nav1.8 primary antibody (1:100) was used against the Nav1.8 alpha-subunit (Alomone, Jerusalem). The secondary antibody was a conjugated AffiniPure goat anti-mouse (1:400) (Molecular Probes). Rabbit Anti-Calnexin polyclonal antibody (1:4,000) was used for endoplasmic reticulum (ER) labeling, and was obtained from StressGen Biotechnologies (Victoria, British Columbia, Canada).

Confocal microscopy

Fluorescent probe-labeled tsA201 cells were examined on a Bio-Rad MRC-1024 confocal imaging system equipped with a krypton-argon laser beam mounted on a Zeiss microscope. A x360 oil objective with a 1:4 numerical aperture was used. Confocal settings were as follows: 1-mw laser power, 1.2 zoom, 1 s per scan, Kalman filter, and 4 frames per image. The photomultiplier gain was adjusted and the aperture adjusted for maximum resolution.

Biotinylation of cell surface proteins

tsA201 cells were cultured in 100-mm dishes and transiently transfected with 5 µg of Nav1.8 and 5 µg of beta1. After transfection (24 h), the cells were treated with 1 mM lidocaine or without (control). After the transfection (48 h), cells were subjected to cell surface biotinylation. Recovery of plasma membrane proteins were carried out using the Pierce cell-surface protein biotinylation and purification kit according to the manufacturer's protocol (Pierce, Rockford, IL). Samples were analyzed by immunoblotting using rabbit anti-Nav1.8 antibody (Alomone) at 1:200 dilution.

Western blot analysis

tsA201 cells were washed with phosphate-buffered saline (PBS, pH 7.4) and solubilized in 1 ml of STEN buffer consisting of: 0.2% NP40, 1% Triton X-100 and protease inhibitor mixture (Roche Molecular Biochemicals, Mannhein, Germany). Insoluble debris were removed by centrifugation at 13,000 rpm for 30 min. Equivalent amounts of proteins were applied to an SDS-10% PAGE electrophoresis gel, and the separated proteins were transferred to a Hybond P membrane (Amersham Pharmacia Biotech, Piscataway, NJ). After protein transfer, the membrane was blocked for 1 h at room temperature in 5% nonfat milk in PBS-T (0.1% tween –20 in PBS, pH 7.4). The membranes were probed with anti-Nav1.8 antibody (1/200 dilution; Alomone), followed by horseradish peroxidase-conjugated goat anti-rabbit (1/10,000 dilution; Amersham Pharmacia Biotech) and ECL detection (Amersham Pharmacia Biotech).


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Lidocaine enhances the cell surface expression of the Nav1.8 channel

Since the cloning of Nav1.8 in 1996 (Sangameswaran et al. 1996Go), the heterologous expression of this Na channel in mammalian cells has proved to be problematic, often resulting in little or no expression of Na current (Okuse et al. 2002Go; Vijayaragavan et al. 2004Go). This has complicated efforts to study the biophysical properties of the heterologously expressed channel. The poor expression of Nav1.8 in cultured cell lines is generally believed to result from a trafficking defect that prevents the channel protein from reaching the plasma membrane (Okuse et al. 2002Go). To further investigate the underlying mechanism, we used immunohistochemistry and confocal imaging to study the subcellular localization of the Nav1.8 channel heterologously expressed in tsA201 cells. Immunofluorescence revealed a significant accumulation of Nav1.8 in perinuclear regions (Fig. 1 A, green staining) that displayed significant overlap with the immunostaining for calnexin, a specific marker of the endoplasmic reticulum (ER; Fig. 1B, red staining). The overlap of the Nav1.8 and calnexin (Fig. 1C, yellow staining) suggests that the majority of the channel protein is localized within intracellular organelles with little distribution to the plasma membrane.


Figure 1
View larger version (40K):
[in this window]
[in a new window]

 
FIG. 1. Subcellular localization the Nav1.8 channel.tsA201 cells were co-transfected with Nav1.8 and the beta1 subunit and the subcellular localization of channel protein determined using antibody labeling and confocal microscopy. A: Nav1.8 immunostaining showing perinuclear localization (Green staining). B: immunofluroescence of the same cells as in A showing the distribution of calnexin (red staining), a protein expressed in endoplasmic reticulum. C: superimposition of Nav1.8 (A) and calnexin (B) staining (orange/yellow). D: pattern of Nav1.8 immunofluorescence (green) after incubating the cells for 24 h with 1 mM lidocaine. E: same cell as in D showing that the subcellular localization of calnexin was not altered by lidocaine preincubation. F: superimposition of Nav1.8 (D) and calnexin (E) staining of lidocaine-treated cells.

 
We found that preincubating Nav1.8-transfected tsA201 cells with lidocaine (1 mM) for 24 h prior to immunohistochemical examination dramatically altered the subcellular distribution of the Nav1.8 channel. Lidocaine substantially reduced the Nav1.8 immunofluorescence of the perinuclear region (Fig. 1D) and reduced the overlap with calnexin (Fig. 1E). Preincubating the cells with lidocaine shifted Nav1.8 staining away from the intracellular compartment and toward the cell periphery (Fig. 1F).

The immunohistochemistry suggests that lidocaine may act by enhancing the trafficking of the Nav1.8 channels from the ER to the plasma membrane. Alternatively, the observed changes in Nav1.8 distribution could have resulted from the synthesis of new channel protein that was specifically targeted to the cell periphery. To distinguish between these alternatives, we used Western blot analysis to investigate the effects of lidocaine on the expression of Nav1.8 channel protein. Figure 2 A shows the Western blot of the Nav1.8 channel expressed in tsA201 cells preincubated under control conditions or after 24-h incubation with lidocaine (1 mM). The expression levels of the Nav1.8 channels were similar under both conditions, suggesting that the increase in peripheral Nav1.8 immunostaining induced by lidocaine (Fig. 1F) does not result from the synthesis of new channel protein.


Figure 2
View larger version (29K):
[in this window]
[in a new window]

 
FIG. 2. Effects of lidocaine on Nav1.8 expression and membrane localization. A: tsA201 cells were co-transfected with Nav1.8 and the beta1 subunit. B: total cell extracts were prepared and the expression of Nav1.8 protein evaluated using Western blots. First lane: 10 µg of protein extracted from Nav1.8/beta1-transfected tsA201 cells nontreated; second lane: equal amount of protein (10 µg) extracted from Nav1.8/beta1 transfected cells preincubated for 24 h with 1 mM lidocaine. Bottom: Western blot of the same protein extract, probed with beta-tubilin specific antibody and used for band quantification. Densitometry analysis showed no difference between nontreated and treated cells. B: Nav1.8 expression at the plasma membrane determined by a combination of biotinylation of cell-surface proteins, isolation of biotinylated proteins on biotin binding columns, and Western blotting (see METHODS). Top: Western blot of nontransfected tsA201 cells, Nav1.8/beta1 transfected cells, and Nav1.8/beta1 transfected cells after 24 preincubation with lidocaine. Middle: Western blots of total cell lysate of nontransfected cells, Nav1.8/beta1 transfected drug-free controls, and Nav1.8/beta1 transfected cells after preincubation with lidocaine. Bottom: Western blot of biotinylated proteins identified using an antibody directed at an intracellular protein (beta-tubilin).

 
The underlying mechanism was further investigated by specifically labeling the Nav1.8 channels expressed on the cell surface of transfected tsA201 cells with biotin. The labeled cells were then lysed, and the biotinylated proteins were purified by NeutrAvidin gel filtration. Figure 2B shows the Western analysis of the biotinylated Nav1.8 channels obtained from control and lidocaine-treated cells. Lidocaine increased the level of Nav1.8 biotinylation by comparison to the drug-free controls. Also shown is the Nav1.8 expression of the total cell lysate, which was not different for control and drug-treated cells. This is in good agreement with standard Western blotting (Fig. 2A) and indicates that lidocaine does not act by nonspecifically increasing the overall expression of Nav1.8 channels. Translation of channel protein does not appear to play an important role in lidocaine-induce appearance of Nav1.8 channels on the cell surface. Rather the increase in Nav1.8 biotinylation and peripheral immunofluroescence (Fig. 1F) supports the proposal that pretreating tsA201 cells with lidocaine promotes the trafficking of existing Nav1.8 channels from the endoplasmic reticulum to the plasma membrane.

Lidocaine enhances the expression of functional Nav1.8 channels in the plasma membrane

Immunohistochemistry indicates that preincubating transfected cells with lidocaine increased the cell surface expression of Nav1.8 channel protein. If these channels are both functional and associated with the plasma membrane, then these findings predict an increase in the Na current amplitude of cells pretreated with the drug. Figure 3 compares the current-voltage relationships of transfected tsA201 cells measured under control conditions and after preincubation with lidocaine. Lidocaine dramatically increased the peak Na current amplitude (Fig. 3B) by comparison to drug-free controls (Fig. 3A). To quantitate these findings, the peak Na current amplitudes were normalized to the whole cell capacitance of individual cells (Fig. 3, C or D). Preincubating with lidocaine induced a significant sixfold increase in the Na current density (–123.3 ± 6.1 pA/pF, n = 12) by comparison to drug-free controls (–23.3 ± 1.6 pA/pF, n = 9, t-test, P < 0.05). The increase in Nav1.8 immunostaining along the cell periphery (Fig. 1) and the parallel increase in Na current density are consistent with our working hypothesis that preincubating cells with lidocaine promotes the re-distribution of functional Nav1.8 channels from intracellular compartments to the plasma membrane.


Figure 3
View larger version (28K):
[in this window]
[in a new window]

 
FIG. 3. Lidocaine increased the Na current density of Nav1.8-transfected cells. Nav1.8 and beta1 subunits were co-expressed in tsA201 cells. A and B: whole cell Na currents of a drug-free control (A) and after 24 h incubation with 1 mM lidocaine (B). Currents were elicited by depolarizing steps between –100 and +90 mV in 10-mV increments from a holding potential of –140 mV. C: peak Na current at each voltage was normalized to the whole cell capacitance and the current density (pA/pf) plotted vs. the test voltage (control, n = 9; lidocaine treated, n = 12). D: at +20 mV, preincubating with lidocaine produced a significant sixfold increase in the Na current density (–123.3 ± 6.1 pA/pf, n = 12) by comparison to the drug-free controls (–23.3 ± 1.6 pA/pf, n = 9, t-test: P < 0.01).

 
To test if the expressed Nav1.8 current was resistant to block by TTX, we tested the effect of 10 µM TTX on our Na currents, a concentration that is known to significantly block the TTX-sensitive channels. A concentration of TTX of 10 µM resulted in only 16% reduction of Na current (Fig. 4), suggesting that the expressed channels are TTX resistant.


Figure 4
View larger version (10K):
[in this window]
[in a new window]

 
FIG. 4. The effect of 10 µM TTX on Nav1.8 currents. Whole cell Nav1.8 currents were evoked every 4 s by 50-ms pulses from –100 to +95 mV in 5-mV increments. The holding potential is –140 mV. —, control current. · · ·, current in the presence of 10 µM TTX for 10 min, the peak current amplitude were inhibited by 16.02 ± 2.6% (n = 7). - - -, 0 current.

 
Activation and inactivation of the heterologously expressed Nav1.8 channel

We took advantage of the enhanced expression of Nav1.8 afforded by lidocaine treatment to further characterize the biophysical properties of the heterologously expressed channel. The time course of the current decay elicited at depolarized voltages was fitted with the sum of two exponentials and the resulting time constants plotted versus voltage (Fig. 5 A). The fast and slow time constants progressively decrease with depolarization, with the fast component accounting for 60–80% of the current decay for voltages between –40 and +70 mV (Fig. 5A, inset). At depolarized voltages where Nav1.8 channels predominately inactivate from the open state (>0 mV), both fast and slow inactivation significantly contribute to the time course of the current decay, similarly to what has been previously described for the native TTX-R current of DRG sensory neurons (Elliott and Elliott 1993Go).


Figure 5
View larger version (28K):
[in this window]
[in a new window]

 
FIG. 5. Properties of the heterologously expressed Nav1.8 channels. Nav1.8 and beta1 subunits were co-expressed in tsA201 cells and preincubated 24 h with lidocaine prior to recording Na current. Test pulses were applied to voltages between –50 and +70 mV and time course of the current decay with a sum of 2 exponential components. A: plot of the fast ({tau}fast) and slow ({tau}slow) time constants of current decay (n = 8). Inset: relative amplitude of the fast component (Afast) as a function of test potential. B: comparison of the steady-state activation and inactivation of controls and after 24-h preincubation with lidocaine. The Na conductance was calculated from the peak Na current measured over a range of potentials, normalized to the conductance at +95 mV, and plotted vs. the test voltage. The smooth curves are fits to a Boltzmann function with midpoints and slope factors (V1/2/kv) of 1.5 ± 2.3 mV/17.5 ± 0.9 mV for the Nav1.8/beta1 transfected controls (n = 9) and –0.6 ± 1.9 mV/13.6 ± 1.0 mV for cells preincubated with lidocaine (n = 12). Steady-state inactivation was determined using 500-ms prepulses to voltages between –140 and +5 mV. Steady-state availability was assayed using a standard test pulse (15 mV/20 ms). The test current amplitudes were normalized to the test currents measured after prepulses to –140 mV (I/Imax) and plotted vs. voltage. The smooth curves are fits to a double Boltzmann function {I/Imax = a*(1/{1+exp[(VV1/21)/kv1]}) + [(1 – a)*(1/{1+exp[(VV1/22)/kv2]})]} with midpoints and slope factors (V1/2/kv) of –71.6 ± 1.2 mV/9.4 ± 0.7 mV for the more hyperpolarized component and –32.9 ± 1.8 mV/9.4 ± 1.0 mV for depolarized component (n = 14). Also plotted is the steady-state availability of the drug-free controls, which had a midpoints and slope factors of –73.4 ± 2.8 mV/10.8 ± 1.3 mV for the more hyperpolarized component and –31.3 ± 3.4 mV/11.5 ± 1.9 mV for the depolarized component (n = 7).

 
The voltage-dependent activation of Nav1.8 was assessed from the peak Na conductance and plotted versus test voltage (Fig. 5B). The smooth curve is a fit to a Boltzmann function with midpoint and slope factor of –0.6 ± 1.9 and 13.6 ± 1.0 mV, respectively (Table 1). Also plotted is the steady-state inactivation determined by applying 500-ms prepulses to voltages between –140 and +10 mV. The availability determined from the peak current amplitudes of standard test pulses was normalized and plotted versus voltage (Fig. 5B). The smooth curve is a fit to a double Boltzmann function with midpoints of –75.1 ± 1.4 and –34.4 ± 3.3 mV, respectively, with the majority of the reduction in availability (76%) being associated with the more hyperpolarized component (n = 9, AH = 0.76 ± 0.03 mV, Table 1). Relatively small but statistically not significant differences in the steady-state activation and inactivation of lidocaine-treated and drug-free controls were observed (Fig. 5B).


View this table:
[in this window]
[in a new window]

 
TABLE 1. Biophysical properties of Na, 1.8 currents in tsA201 cells after 1 mM lidocaine treatment and TTX-R currents in DRG neurons

 
The biphasic steady-state inactivation (Fig. 5B) suggests that more than one gating process may contribute to the inactivation of Nav1.8 over a hyperpolarized range of voltages. To further investigate the underlying mechanism(s), we varied the duration of the depolarizing conditioning pulses used to induce steady-state inactivation. Figure 6 A plots the normalized test currents versus the voltage for conditioning durations of 50, 100, and 500 ms. The smooth curves are double Boltzmann fits with midpoints of –75.1 and –34.4 mV for the 500-ms prepulses (AH = 0.76), –75.0 and –31.5 mV for the 100-ms prepulses (AH = 0.67), and –75.2 and –33.6 mV for the 50- ms prepulses (AH = 0.53). Shortening the duration of the prepulses had no effect on the midpoints of inactivation but significantly reduced the relative amplitude (AH) of the more hyperpolarized component (t-test, P < 0.05). These finding indicate that the longer prepulses (>50 ms) promoted the entry of Nav1.8 channels into a slow inactivated state that inactivated over a more hyperpolarized range of voltages.


Figure 6
View larger version (25K):
[in this window]
[in a new window]

 
FIG. 6. Slow inactivation is an important determinant of steady-state availability. Nav1.8 and beta1 subunits were expressed in tsA201 cells and exposed to 1 mM lidocaine for 24 h prior to recording. The steady-state availability was determined by applying prepulses of variable duration (50, 100, or 500 ms) to voltages between –140 and +5 mV. A standard test pulse (20 mv/20 ms) was then used to assay availability. The test currents were normalized and plotted vs. the prepulse voltage. A: steady-state availability was determined using the 50-, 100-, and 500-ms prepulse durations. The smooth curves are fits to a double Boltzmann function with the parameters listed in Table 1. B: steady-state slow inactivation was determined by applying 500 ms to voltages between –140 and +5 mV. A short hyperpolarizing pulse (10 ms/–140 mV) was applied to permit recovery from fast inactivation and standard test pulse used to assay availability (+15 mV/20 ms). The test currents were normalized and plotted vs. voltage. The smooth curve is a fit to a Boltzmann function [I/Imax = ((1 – A)/{1 + exp[(VV1/2)/kv]} + A)] with midpoint (V1/2), slope factor (kv) and steady-state availability (A) of –71.6 ± 1.8 mV, 11.8 ± 1.0 mV, and 0.61 ± 0.02, respectively (n = 12).

 
To directly investigate the contribution of slow inactivation to the steady-state availability, a triple pulse protocol was employed consisting of a 500-ms conditioning pulse to induce inactivation followed by a short hyperpolarization (–140 mV/10 ms) to permit the recovery from fast inactivation. A standard test pulse was then applied to assay availability. The relative amplitude of the test pulses decreases with depolarization, consistent with a progressive increase in slow inactivation (Fig. 6B). The smooth curve is a fit to a Boltzmann function with midpoint (V1/2) of –71.6 ± 1.8 mV and relative amplitude of 0.39 ± 0.01 (n = 12). The midpoint of steady-state slow inactivation and amplitude are similar to the hyperpolarized component of availability (V1/2 = –71.6, AH = 0.51) obtained using conventional steady-state inactivation protocols (Table 1). The kinetics of closed-state inactivation at hyperpolarized voltages was also investigated (Fig. 7 A). The closed-state inactivation time course was biexponential with fast and slow time constants. For example the time constants at –70 mV are 15.2 ± 1.7 and 211.1 ± 22.2 ms, respectively (n = 18). The amplitude of the fast time constant represents 31%. These data further support the conclusion that Nav1.8 channels readily enter into slow inactivated states at hyperpolarized voltages where the channels do not open.


Figure 7
View larger version (24K):
[in this window]
[in a new window]

 
FIG. 7. Time course of Nav1.8 closed-state inactivation and recovery. A: development of closed-state inactivation was determined by depolarizing to voltages between –80 and –60 mV for variable intervals (1 s) from a holding potential of –120 mV. The fractional inactivation was assessed by applying a standard test pulse (+15 mV/20 ms), and the normalized test currents plotted vs. the prepulse duration. The smooth curves are the sum of 2 exponential components with fast and slow time constants of 16.4 ± 2.2 ms and 188.1 ± 19.8 at –80 mV (n = 19) with the amplitude of the fast components, Af = 0.21 ± 0.01; 15.2 ± 1.7 ms and 211.1 ± 22.2 ms at –70 mV (n = 18), Af = 0.31 ± 0.03; and 11.0 ± 0.8 ms 161.2 ± 22.7 ms at –60 mV (n = 20), Af = 0.24 ± 0.04. B: time course of recovery from inactivation was determined by first applying depolarizing prepulses (+15 mV/20 ms) before returning to a hyperpolarized potential (Vrec = –120, –110, –100 mV) for a variable interval (1 ms –1 s) to promote recovery. The fractional recovery at each time point was assessed with a standard test pulse (+15 mV/20 ms). The test current amplitudes were normalized and plotted versus the recovery interval. The smooth curves fits of the data to the sum of 2 exponential components with fast and slow time constants of: 1.8 ± 0.3 and 12.7 ± 3.4 ms at –120 mV (Af = 0.53, n = 11), 2.2 ± 0.3 ms and 20.6 ± 4.3 at –110 mV (Af = 0.6, n = 11), and 2.7 ± 0.5 ms and 29.8 ± 6.1 ms at –100 mV (Af = 0.6, n = 11).

 
The time course of recovery from inactivation was investigated using a double-pulse protocol consisting of a depolarizing prepulse (+15 mV/20 ms) to inactivate the channels, a variable duration recovery pulse to voltages between –120 and –90 mV, and a standard test pulse. The amplitudes of the test currents were normalized and plotted versus the recovery interval (Fig. 7B). The normalized test currents progressively increase with the duration of the recovery interval consistent with the rapid recovery from inactivation. At –120 mV, the recovery time course was biexponential with fast and slow time constants of 1.8 ± 0.3 and 12.7 ± 3.4 ms, respectively (n = 11, Af = 0.53).

The biexponential kinetics of closed-state inactivation (Fig. 7A), the recovery (Fig. 7B), and the biphasic Boltzmann relationship (Fig. 6A) indicate that both fast and slow inactivation are important determinants of the steady-state availability of the Nav1.8 channel.

Nav1.8 single-channel currents

Figure 8, A and B, shows single-channel recordings of the Nav1.8 channel heterologously expressed in tsA201 cells. At –10 mV, the channels rapidly open near the beginning of the voltage pulses and appear to close and repeatedly re-open during the 160-ms depolarization. Figure 8C shows the ensemble average reconstructed from the single-channel openings at –10 mV, which displayed a typical slow inactivation time course similar to what was observed for the macroscopic Nav1.8 current (Fig. 3B). Repeated opening and comparatively long open times accounts for the slow time-dependent current decay and may underlie the persistent component of Nav1.8 current observed at depolarized voltages (Fig. 3A). This contrasts with test pulses to –30 mV, which are near the foot of the conductance-voltage relationship (Fig. 5B). Consequently the channels tend to open later during the voltage pulse, the first latency at –10 mV, was estimated to 6.4 ± 1.0 ms, and have shorter open times (0.50 ± 0.01 ms), presumably due to rapid closing at the more hyperpolarized potential.


Figure 8
View larger version (29K):
[in this window]
[in a new window]

 
FIG. 8. Single-channel properties of heterologously expressed Nav1.8. Nav1.8 and beta1 subunit were co-expressed in tsA201 cells and exposed to 1 mM lidocaine for 24 h prior to recording. A and B: representative single-channel currents recorded in cell-attached configuration at –10 mV (A) and –30 mV (B). Currents were elicited from a holding potential of –120 mV. C: ensemble average of the single-channel openings measured at –10 mV. D: all-points histogram of the single-channel current amplitudes at –10 mV. The smooth curve is a Gaussian fit with amplitude peaks at 0.75 and –10 mV. E: plot of the current-voltage relationship. The straight line is a linear regression yielding a unitary conductance of 11.0 ± 0.4 pS. Data represents mean amplitudes obtained from 9 to 14 individual patches.

 
Figure 8D shows the all-points histogram of the Nav1.8 channel at –10 mV, which indicates single-channel current amplitude of 0.75 pA. The single-channel current amplitudes were measured over a range of voltages and plotted versus the test voltage (Fig. 8E). The data were well fitted with a straight line yielding a single-channel conductance of 11 ± 0.4 pS.

Properties of the TTX-resistant Na current of DRG neurons

Preincubating with lidocaine increased the cell surface expression (Fig. 1) and Na current density (Fig. 3) of tsA201 cells transiently transfected with the Nav1.8 channel. Although these data are consistent with an increase in the expression of functional Nav1.8 channels in the plasma membrane, it is important to ascertain that the resulting Na currents have properties that are similar to the native TTX-R current of DRG neurons. We therefore directly compared the properties of the heterologously expressed Nav1.8 and native DRG Na current. Figure 9 shows whole cell Na current recordings from a dissociated DRG neuron before and after external application of TTX (Fig. 9). TTX reduced the peak current amplitude and slowed the kinetics of current decay, consistent with the selective inhibition of the rapidly gating TTX-S Na current expressed in these neurons. Figure 9D shows the current-voltage relationships of these Na currents. Consistent with what has been previously reported, the TTX-R current of DRG neurons activates at more depolarized voltages and displays slow gating kinetics by comparison to the TTX-S current (Elliott and Elliott 1993Go).


Figure 9
View larger version (33K):
[in this window]
[in a new window]

 
FIG. 9. TTX-resistant Na current of dorsal root ganglion (DRG) neurons. Neurons were isolated from the rat DRG. A: whole cell Na current of a small (17 pf) DRG neuron elicited by depolarizing pulses between –70 and +55 mV in 5-mV increments from a holding potential of –80 mV. B: TTX-resistant (TTX-R) current measured after the bath application of 300 nM TTX. C: TTX-sensitive (TTX-S) current obtained by subtracting the TTX-R component from the total current. D: current-voltage relationships of the Total, TTX-R and TTX-S components of DRG Na current (n = 11).

 
Figure 10 A shows the normalized conductance and steady-state availability of the TTX-R Na current of DRG neurons. The voltage-dependent activation of the TTX-R current was fitted by a Boltzmann function with a midpoint of –13.8 ± 1.7 mV (n = 11). Also plotted is the steady-state inactivation obtained using 500-ms prepulses to voltages between –120 and 0 mV. The data were best fitted by the sum of two Boltzmann functions with midpoints of –77 ± 4 and –32 ± 2 mV (n = 8), respectively, and are in good agreement with those determined for the heterologously expressed Nav1.8 channel (Table 1). The time course of recovery from inactivation was bi-exponential with fast ({tau}f) and slow ({tau}s) time constants of 0.9 ± 0.4 and 74.5 ± 12.0 ms (Af = 0.74, n = 3), respectively (Fig. 10B). By comparison to heterologously expressed Nav1.8, fewer of the endogenous TTX-R channels recovered with the slower time constant (53% for TTX-R vs. 75% for Nav1.8). This is consistent with measurements of steady-state inactivation where the relative fraction of native TTX-R channels inactivating at the more hyperpolarized voltage (AH = 0.12 ± 0.02, n = 8) was small by comparison to what was observed for the heterogously expressed Nav1.8 channels (AH = 0.76 ± 0.03, n = 9). In addition, the endogenous TTX-R channels that entered into the slow inactivated state recovered slowly ({tau}s = 74.6 ms) by comparison to the heterologously expressed channels ({tau}s = 12.7 ms). These data suggest significant differences in the slow inactivation of the endogenous and heterologously expressed Nav1.8 channels.


Figure 10
View larger version (23K):
[in this window]
[in a new window]

 
FIG. 10. Voltage-dependent gating of the TTX-R Na current of DRG neurons. A: conductance [G = I/(VVr)] was determined from the peak Na current (I) at each test voltage (V) and the reversal potential (Vr) determined from the current-voltage relationships (Fig. 9D). The conductance was normalized to that determined at +60 mV and plotted vs. voltage. The smooth curve is a fit to a Boltzmann function with midpoint (V1/2) and slope factor (kv) of –13.8 ± 1.7 and 6.0 ± 0.6 mV, respectively (n = 11). Steady-state inactivation was determined using 500-ms prepulses to the indicated voltages. The smooth curve is a fit of the data to a double Boltzmann function with V1/2 and kv of –77.13 ± 4.0 and 16.0 ± 0.51 mV for the hyperpolarized component (AH = 0.12 ± 0.02) and –31.6 ± 1.5 and 4.1 ± 0.2 mV for the more depolarized component (n = 8). Parameters are listed in Table 1. B: time course of recovery from inactivation. Depolarizing prepulses (20 mV/75 ms) were applied before returning to a holding potential of –120 mV for a variable interval (0.05–1 s). The fractional recovery was determined using a standard test pulse (20 mV/10 ms). The test currents were normalized to the current measured after >1 s at –120 mV and plotted vs. recovery interval. The smooth curve is a fit to the sum of 2 exponentials with fast and slow time constants ({tau}) of 0.9 ± 0.38 and 74.5 ± 12.1 ms (Af = 0.74 ± 0.05, n = 3). C: time course of rapid inactivation. The decay phase of the TTX-R current measured at voltages more depolarized than –25 mV was fitted with the sum of 2 exponential components and the resulting fast ({tau}fast) and slow ({tau}slow) time constants plotted vs. voltage (n = 8).

 
Figure 10C shows the time constants of current decay at depolarized voltages where Nav1.8 channel open before inactivating. The current decay is biexponential with the rapid accounting for the majority (75–99%) of the current decay at voltages between 0 and +35 mV. The time constants and relative amplitudes of the fast and slow components are similar to what was observed for the heterologously expressed Nav1.8 channel (Fig. 5A).


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
The Nav1.8 channel is preferentially expressed in unmyelinated (C-type) and thinly myelinated (A{delta}) fibers of peripheral nerve and significantly contributes to the rapid upstroke and conduction of nociceptor action potentials (Renganathan et al. 2001Go). Insights into the biophysical properties of the Nav1.8 channel have been largely obtained from studies of the endogenous TTX-R Na current of small cell bodies isolated from the DRG (Elliott and Elliott 1993Go). Unfortunately, DRG sensory neurons express multiple components of TTX-R Na currents that complicate the detailed characterization of voltage dependence and kinetics of the individual currents (Renganathan et al. 2001Go). Establishing an approach for heterologously expressing Nav1.8 in cells that are devoid of endogenous Na current would enable a more-detailed characterization of the channel. Unfortunately, the heterologously expression of the cloned Nav1.8 channel in mammalian cell lines has proved to be problematic (Choi et al. 2004Go; Fitzgerald et al. 1999Go; John et al. 2004Go; Okuse et al. 2002Go; Zhou et al. 2003Go; Vijayaragavan et al. 2001Go; Vijayaragavan et al. 2004Go). Nav1.8 transfection of cultured cell lines often results in peak Na currents (<1 nA) that are considerably smaller than the endogenous TTX-R current of isolated DRG sensory neurons (>10 nA). Although the reason for this low level of expression is not known, it may be caused by a trafficking defect that prevents the incorporation of Nav1.8 channels into the plasma membrane (Okuse et al. 2002Go). Co-expression of accessory proteins have been shown to increase heterologously expressed Nav1.8 currents (John et al. 2004Go; Vijayaragavan et al. 2001Go); however, the mechanisms that govern the cell surface expression of these channels remains poorly understood.

In this study, we found that preincubating Nav1.8-transfected tsA201 cells with lidocaine produced a sixfold increase in the amplitude of the TTX-R Na current. To further investigate the underlying mechanism, we directly compared the biophysical properties of the TTX-R currents of lidocaine-treated tsA201 cells with the native TTX-R Na current of dissociated rat DRG neurons. Both the Nav1.8 and native TTX-R Na currents activated at voltages around –50 mV. The time constants of current decay were similar for both Na currents indicating that the underlying channels slowly inactivate at depolarized voltages where the channels were predominately open (Figs. 5C and 10, A and B). Single-channel recordings of the heterogously expressed channel displayed repetitive opening during sustained depolarization that appears to account for the slow time course of inactivation and the small persistent currents observed in macroscopic recordings (Fig. 3B). The single conductance of heterologously expressed Nav1.8 was 11 ± 1.0 pS (Fig. 8D) and is in good agreement with that previously reported for the endogenous TTX-resistant Na current of DRG neurons (Rush et al. 1998Go).

The activation of the heterologously expressed Nav1.8 and native TTX-R Na currents had midpoints (V1/2) of –0.6 and –13.8 mV, respectively (Table 1). The relatively hyperpolarized midpoint of activation observed for the endogenous TTX-R current is similar to what has been previously reported (Akiba et al. 2003Go; Liu et al. 2006Go). We speculate that the difference in the activation of the heterologously expressed and endogenous Na currents may be related to the expression of additional components of TTX-R current (Nav1.5 and Nav1.9) in DRG neurons but not tsA201 cells (Fang et al. 2002Go; Renganathan et al. 2002Go). Alternatively, DRG neurons may express additional subunits or accessory proteins that regulate the gating of the Nav1.8 channel.

The steady-state inactivation of heterologously expressed Nav1.8 obtained using 500-ms prepulses was fitted by a double Boltzmann function with midpoints of –75.1 ± 1.4 and –34.4 ± 3.3 mV, indicating that two distinct components of inactivation contribute to the availability of the heterologously expressed channels (Table 1). We found that shortening the depolarizing prepulses from 500 to 50 ms had no effect on the midpoints (V1/2) of inactivation but significantly reduced the relative amplitude of the more hyperpolarized component (Fig. 6A). The data suggested that the longer prepulses recruited channels into slow inactivated states that inactivated over a more hyperpolarized range of voltages. To test this mechanism, we directly measured the steady-state slow inactivation of Nav1.8 channels (Fig. 6B), which had a midpoint (V1/2 = –71.6 ± 1.8 mV) that was nearly identical to the more hyperpolarized component of inactivation (V1/2 = –75.1 ± 1.4 mV) obtained using the conventional protocols for measuring steady-state availability (Fig. 5D). The data indicate that Nav1.8 channels rapidly enter into slow inactivated states at hyperpolarized voltages and that both fast and slow inactivation are important determinants of the steady-state availability of Nav1.8 channels. Consistent with this hypothesis is the time course of the development of inactivation at hyperpolarized voltages where Nav1.8 channels do not open before inactivating, which was found to be biexponential (Fig. 5A). The time constant of the slow component was in a range of 161–211 ms and appears to be associated with the entry of Nav1.8 channels into a slow inactivated state. The hallmark of Nav1.8 is its insensitivity to TTX, still our data show that the expressed Na channels were resistant to block by TTX (Fig. 4).

The steady-state availability of the endogenous TTX-R current of DRG neurons was fitted by a double Boltzmann with midpoints of –77.1 and –31.6 mV, similar to what was observed for the heterologously expressed channels (Fig. 10). Although the midpoints of fast and slow inactivation of the Nav1.8 and TTX-R currents were similar, the relative contributions of these components to the steady-state availability substantially differed. When applying 500-ms depolarizing prepulses the majority (88%) of the native TTX-R current was associated with the more depolarized component (Fig. 10A) versus only 24% for heterologously expressed Nav1.8 (Fig. 6A). By comparison to the heterologously expressed channels, the endogenous TTX-R channel of DRG neurons appeared to be more resistant to entry into the slow inactivated state. We speculate that this may result from differential regulation of the expressed and endogenous channels by accessory subunits or intracellular signaling pathways that are unique to DRG neurons.

Overall, the slow open-state inactivation (Fig. 5A), the relatively depolarized midpoints of activation and inactivation (Fig. 5B), and the rapid recovery from inactivation (Fig. 7B) are similar for the heterologous expressed Nav1.8 and native TTX-R Na currents. These data indicate that preincubating tsA201 cells with lidocaine selectively increased the cell surface expression of Nav1.8 channels but did not significantly alter their biophysical properties. The activation and steady-state inactivation of the Nav1.8 channel considerably overlap between –60 and 0 mV suggesting that depolarizing window currents may contribute to the resting membrane potential of DRG neurons expressing this channel.

The increase in Nav1.8 current density produced by lidocaine suggested that preincubating with the drug promoted the translocation of Nav1.8 channels to the plasma membrane. To further investigate the underlying mechanism, we examined the subcellular distribution of the heterologously expressed Nav1.8 channels using confocal fluorescent imaging. In control experiments, the Nav1.8 immunostaining largely overlapped with that of calnexin, a specific marker of endoplasmic reticulum (Fig. 1). When expressed in tsA201 cells the majority of the Nav1.8 channel protein appears to be trapped within the endoplasmic reticulum, which would account for the relatively low Na current density of the transfected cells (Fig. 3A). Preincubating the transfected cells with lidocaine resulted in a substantial shift of Nav1.8 immunofluorescence from the cytoplasm to the cell membrane that correlated with an increase in the Na current density (Fig. 3D). Western blot analysis indicated that the increase in cell surface immunostaining and Na current density induced by lidocaine was not associated with a parallel increase in the expression of the Nav1.8 channel protein (Fig. 2). Rather these findings indicate that the increase in functional Na channels results from the redistribution of preexisting Nav1.8 channels from the cytoplasmic compartment to the plasma membrane. These data suggest that the overall poor expression of the Nav1.8 in tsA201 cells, and possibly other mammalian cell lines (Fitzgerald et al. 1999Go; Okuse et al. 2002Go), results from a trafficking defect that causes channel protein to become trapped in the endoplasmic reticulum. The local anesthetic lidocaine is a potent inhibitor of the Nav1.8 channel that is known to act by stabilizing Na channels in nonconducting inactivated states (Chevrier et al. 2004Go). However, we cannot rule out the possibility that lidocaine can interact with other proteins such as GPCRs (Hollmann et al. 2001Go). Although the state of Na channel in the ER is not known, we speculate that the lidocaine-modified Nav1.8 channels are stabilized in a conformational that facilitates the trafficking of the channels to the plasma membrane.


    GRANTS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
The study was supported by the Heart and Stroke Foundation of Québec, Canadian Institutes of Health Research Grant MT-13181. Dr. M. Chahine is an Edwards Senior Investigator (Joseph C. Edwards Foundation).


    FOOTNOTES
 
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Address for reprint requests and other correspondence: M. Chahine, Le Centre de Recherche Université Laval Robert-Giffard, 2601 Chemin de la Canardière, Québec, Québec G1J 2G3, Canada (E-mail: mohamed.chahine{at}phc.ulaval.ca)


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Akiba I, Seki T, Mori M, Iizuka M, Nishimura S, Sasaki S, Imoto K, Barsoumian EL. Stable expression and characterization of human PN1 and PN3 sodium channels. Receptors Channels 9: 291–299, 2003.[ISI][Medline]

Akopian AN, Sivilotti L, Wood JN. A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons. Nature 379: 257–262, 1996.[CrossRef][Medline]

Akopian AN, Souslova V, England S, Okuse K, Ogata N, Ure J, Smith A, Kerr BJ, McMahon SB, Boyce S, Hill R, Stanfa LC, Dickenson AH, Wood JN. The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways. Nat Neurosci 2: 541–548, 1999.[CrossRef][ISI][Medline]

Chahine M, Pilote S, Pouliot V, Takami H, Sato C. Role of arginine residues on the S4 segment of the Bacillus halodurans Na+ channel in voltage-sensing. J Membr Biol 201: 9–24, 2004.[CrossRef][ISI][Medline]

Chevrier P, Vijayaragavan K, Chahine M. Differential modulation of Nav1.7 and Nav1.8 peripheral nerve sodium channels by the local anesthetic lidocaine. Br J Pharmacol 142: 576–584, 2004.[CrossRef][ISI][Medline]

Choi JS, Tyrrell L, Waxman SG, Dib-Hajj SD. Functional role of the C-terminus of voltage-gated sodium channel Na(v)1.8. FEBS Lett 572: 256–260, 2004.[CrossRef][ISI][Medline]

Cummins TR, Dib-Hajj SD, Black JA, Akopian AN, Wood JN, Waxman SG. A novel persistent tetrodotoxin-resistant sodium current in SNS-null and wild-type small primary sensory neurons. J Neurosci 19: RC43, 1999.

Elliott AA, Elliott JR. Characterization of TTX-sensitive and TTX-resistant sodium currents in small cells from adult rat dorsal root ganglia. J Physiol 463: 39–56, 1993.[Abstract/Free Full Text]

Fang X, Djouhri L, Black JA, Dib-Hajj SD, Waxman SG, Lawson SN. The presence and role of the tetrodotoxin-resistant sodium channel Nav1.9 (NaN) in nociceptive primary afferent neurons. J Neurosci 22: 7425–7433, 2002.[Abstract/Free Full Text]

Fitzgerald EM, Okuse K, Wood JN, Dolphin AC, Moss SJ. cAMP-dependent phosphorylation of the tetrodotoxin-resistant voltage-dependent sodium channel SNS. J Physiol 516: 433–446, 1999.[Abstract/Free Full Text]

Fjell J, Hjelmstrom P, Hormuzdiar W, Milenkovic M, Aglieco F, Tyrrell L, Dib-Hajj S, Waxman SG, Black JA. Localization of the tetrodotoxin-resistant sodium channel NaN in nociceptors. Neuroreport 11: 199–202, 2000.[ISI][Medline]

Hille B. Ionic Channels of Excitable Membranes. Sunderland, MA: Sinauer, 2001.

Hollmann MW, Difazio CA, Durieux ME. Ca-signaling G-protein-coupled receptors: a new site of local anesthetic action? Reg Anesth Pain Med 26: 565–571, 2001.[CrossRef][ISI][Medline]

John VH, Main MJ, Powell AJ, Gladwell ZM, Hick C, Sidhu HS, Clare JJ, Tate S, Trezise DJ. Heterologous expression and functional analysis of rat NaV1.8 (SNS) voltage-gated sodium channels in the dorsal root ganglion neuroblastoma cell line ND7-23. Neuropharmacology 46: 425–438, 2004.[CrossRef][ISI][Medline]

Kostyuk PG, Veselovsky NS, Tsyndrenko AY. Ionic currents in the somatic membrane of rat dorsal root ganglion neurons. I. Sodium currents. Neuroscience 6: 2423–2430, 1981.[CrossRef][ISI][Medline]

Liu C, Cummins TR, Tyrrell L, Black JA, Waxman SG, Dib-Hajj SD. CAP-1A is a novel linker that binds clathrin and the voltage-gated sodium channel Na(v)1.8. Mol Cell Neurosci 28: 636–649, 2005.[CrossRef][ISI][Medline]

Liu CJ, Priest BT, Bugianesi RM, Dulski PM, Felix JP, Dick IE, Brochu RM, Knaus HG, Middleton RE, Kaczorowski GJ, Slaughter RS, Garcia ML, Kohler MG. A high-capacity membrane potential FRET-based assay for NaV1.8 channels. Assay Drug Dev Technol 4: 37–48, 2006.[CrossRef][ISI][Medline]

Margolskee RF, McHendry-Rinde B, Horn R. Panning transfected cells for electrophysiological studies. Biotechniques 15: 906–911, 1993.[ISI][Medline]

McCleskey EW, Gold MS. Ion channels of nociception. Annu Rev Physiol 61: 835–856, 1999.[CrossRef][ISI][Medline]

Morello JP, Petäjä-Repo UE, Bichet DG, Bouvier M. Pharmacological chaperones: a new twist on receptor folding. Trends Pharmacol Sci 21: 466–469, 2000.[CrossRef][Medline]

Ogata N, Tatebayashi H. Kinetic analysis of two types of Na+ channels in rat dorsal root ganglia. J Physiol 466: 9–37, 1993.[Abstract/Free Full Text]

Okuse K, Malik-Hall M, Baker MD, Poon WYL, Kong H, Chao MV, Wood JN. Annexin II light chain regulates sensory neuron-specific sodium channel expression. Nature 417: 653–656, 2002.[CrossRef][Medline]

Renganathan M, Cummins TR, Waxman SG. Contribution of Nav1.8 sodium channels to action potential electrogenesis in DRG neurons. J Neurophysiol 86: 629–640, 2001.[Abstract/Free Full Text]

Renganathan M, Dib-Hajj S, Waxman SG. Na(v)1.5 underlies the ‘third TTX-R sodium current’ in rat small DRG neurons. Brain Res Mol Brain Res 106: 70–82, 2002.[Medline]

Roy ML, Narahashi T. Differential properties of tetrodotoxin-sensitive and tetrodotoxin-resistant sodium channels in rat dorsal root ganglion neurons. J Neurosci 12: 2104–2111, 1992.[Abstract]

Rush AM, Bräu ME, Elliott AA, Elliott JR. Electrophysiological properties of sodium current subtypes in small cells from adult rat dorsal root ganglia. J Physiol 511: 771–789, 1998.[Abstract/Free Full Text]

Sangameswaran L, Delgado SG, Fish LM, Koch BD, Jakeman LB, Stewart GR, Sze P, Hunter JC, Eglen RM, Herman RC. Structure and function of a novel voltage-gated, tetrodotoxin-resistant sodium channel specific to sensory neurons. J Biol Chem 271: 5953–5956, 1996.[Abstract/Free Full Text]

Sangameswaran L, Fish LM, Koch BD, Rabert DK, Delgado SG, Ilnicka M, Jakeman LB, Novakovic S, Wong K, Sze P, Tzoumaka E, Stewart GR, Herman RC, Chan H, Eglen RM, Hunter JC. A novel tetrodotoxin-sensitive, voltage-gated sodium channel expressed in rat and human dorsal root ganglia. J Biol Chem 272: 14805–14809, 1997.[Abstract/Free Full Text]

Scholz A, Kuboyama N, Hempelmann G, Vogel W. Complex blockade of TTX-resistant N